Roche to jettison 500 in Palo Alto

Five hundred Roche employees will be laid off as the Swiss pharmaceutical giant Roche prepares to close its Palo Alto research offices, the firm disclosed. The layoffs will begin in late summer and continue over the following 12 months as operations wind down, said Jacqueline Wallach, vice president of communications. Report

Suggested Articles

Amarin Vascepa pill
Pharma

Amarin's Vascepa sails through FDA panel vote toward new CV nod

It's taken years for Amarin's Vascepa to prove itself as a game-changing treatment for CV disease. An FDA committee may have just punched its pass.

by Kyle Blankenship
Fujifilm Diosynth Biotechnologies in Texas
Manufacturing

Fujifilm investing $120M in U.S. gene therapy operations

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

by Eric Palmer
Falcon 9 launch
Marketing

Intercept amps up sales force ahead of potential NASH rollout

With a potential approval next year in the up-and-coming NASH field, Intercept is staffing up its sales team and starting talks with payers.

by Eric Sagonowsky